Predictive Oncology Inc. (POAI)
USD 0.73
(-1.35%)
USD 0.73
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.78 Million | 1.5 Million | 1.42 Million | 1.25 Million | 1.41 Million | 1.41 Million |
| Cost of Revenue | 634.79 Thousand | 505.1 Thousand | 487.02 Thousand | 447.19 Thousand | 531.81 Thousand | 415.76 Thousand |
| Gross Profit | 1.14 Million | 1 Million | 933.65 Thousand | 805.08 Thousand | 879.75 Thousand | 995.89 Thousand |
| Operating Expenses | 15.22 Million | 16.26 Million | 14.4 Million | 13.28 Million | 14.65 Million | 8.85 Million |
| Selling, General and Administrative Expenses | 15.06 Million | 12.46 Million | 11.7 Million | 10.93 Million | 11.69 Million | 6.99 Million |
| Research and Development Expenses | 188.3 Thousand | 320.32 Thousand | 315.85 Thousand | 2.35 Million | 2.96 Million | 1.86 Million |
| Other Expenses | - | 3.79 Million | 2.69 Million | -1.58 Million | -2.47 Million | 68.48 Thousand |
| Cost and Expenses | 15.7 Million | 16.77 Million | 14.89 Million | 13.73 Million | 15.18 Million | 9.27 Million |
| Operating Income | -13.92 Million | -15.26 Million | -13.47 Million | -666.26 Thousand | -13.77 Million | -7.86 Million |
| Interest Expense | - | 10.65 Million | - | - | - | - |
| Income Tax Expense | - | 10.46 Million | -661.65 Thousand | 11.81 Million | 8.16 Million | -2.22 Million |
| Earnings before Tax | -13.98 Million | -25.73 Million | -20.31 Million | -25.88 Million | -19.39 Million | -10.08 Million |
| Net Income | -13.98 Million | -36.2 Million | -19.65 Million | -37.7 Million | -27.55 Million | -10.08 Million |
| Earnings Per Share Basic | -3.48 | -9.92 | -7.16 | -63.10 | -192.02 | -157.40 |
| Earnings Per Share Diluted | -3.48 | -9.92 | -7.16 | -63.10 | -192.02 | -157.40 |
| Weighted Average Shares Outstanding | 4.01 Million | 3.64 Million | 2.74 Million | 597.5 Thousand | 143.5 Thousand | 64.08 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.01 Million | 3.64 Million | 2.74 Million | 597.5 Thousand | 143.5 Thousand | 64.08 Thousand |
| Gross Margin | 0.64 | 0.66 | 0.66 | 0.64 | 0.62 | 0.71 |
| EBIT Margin | -7.41 | -2.19 | -4.70 | 0.29 | -3.47 | -5.46 |
| Profit Margin | -7.86 | -24.05 | -13.84 | -30.11 | -19.52 | -7.15 |
| EBITDA | -13.18 Million | -13.95 Million | -12.13 Million | -11.45 Million | -12.41 Million | -7.71 Million |
| Earnings Before Tax Margin | -7.82 | -10.14 | -9.48 | -0.53 | -9.76 | -5.57 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 278.72 Thousand | 419.64 Thousand | 1.78 Million | 335.03 Thousand | 715.05 Thousand | 490.11 Thousand |
| Cost of Revenue | 317.13 Thousand | 349.98 Thousand | 1.34 Million | 406.29 Thousand | 106.94 Thousand | 159.76 Thousand |
| Gross Profit | -38.41 Thousand | 69.66 Thousand | 433.4 Thousand | -71.26 Thousand | 608.11 Thousand | 330.34 Thousand |
| Operating Expenses | 3.15 Million | 4.3 Million | 14.35 Million | 3.43 Million | 3.76 Million | 4.12 Million |
| Selling, General and Administrative Expenses | 3.15 Million | 4.3 Million | - | 3.33 Million | 2.91 Million | 3.13 Million |
| Research and Development Expenses | - | - | - | 99.46 Thousand | 20.67 Thousand | 29.36 Thousand |
| Other Expenses | 7627.00 | 16.92 Thousand | 87.8 Thousand | 29.86 Thousand | -12.83 Thousand | 28.55 Thousand |
| Cost and Expenses | 3.46 Million | 4.65 Million | 15.7 Million | 3.84 Million | 3.86 Million | 4.28 Million |
| Operating Income | -3.18 Million | -4.23 Million | -13.92 Million | -3.5 Million | -3.15 Million | -3.95 Million |
| Interest Expense | - | - | - | -835.33 Thousand | - | - |
| Income Tax Expense | 5.00 | 5.00 | 4.00 | -987.47 Thousand | -3463.00 | 155.59 Thousand |
| Earnings before Tax | -3.18 Million | -4.21 Million | -13.98 Million | -3.47 Million | -3.16 Million | -3.92 Million |
| Net Income | -3.18 Million | -4.21 Million | -13.98 Million | -3.47 Million | -3.16 Million | -3.92 Million |
| Earnings Per Share Basic | -0.68 | -1.04 | - | -0.86 | -0.78 | -0.98 |
| Earnings Per Share Diluted | -0.68 | -1.04 | - | -0.86 | -0.78 | -0.98 |
| Weighted Average Shares Outstanding | 4.66 Million | 4.06 Million | 4.01 Million | 4.06 Million | 4.03 Million | 3.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.66 Million | 4.06 Million | 4.01 Million | 4.06 Million | 4.03 Million | 3.99 Million |
| Gross Margin | -0.14 | 0.17 | 0.24 | -0.21 | 0.85 | 0.67 |
| EBIT Margin | -10.85 | -9.71 | - | -9.99 | -4.19 | -7.06 |
| Profit Margin | -11.41 | -10.05 | -7.86 | -10.37 | -4.42 | -8.01 |
| EBITDA | -3.02 Million | -4.07 Million | - | -3.34 Million | -2.99 Million | -3.46 Million |
| Earnings Before Tax Margin | -11.44 | -10.10 | -7.82 | -10.46 | -4.41 | -8.08 |
AMGRF
MAHABANK
INUMF
DANUBE
2683
SOAR